Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPain ManagementAetna Transforaminal Epidural Injections Coverage …
    Ask Trek AI about this page
    CurrentAetnaPolicy 0722

    Transforaminal Epidural Injections

    Customize your policy alerts

    Sign up for Aetna Policy 0722 alerts

    Get alerted when Policy 0722 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage and medical necessity criteria for diagnostic and therapeutic transforaminal epidural steroid injections (TFESIs), including limits on frequency, levels treated, guidance requirements, and investigational indications; applies to Aetna members/providers.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerAetna
    PolicyTransforaminal Epidural Injections
    Policy CodePolicy 0722
    Change TypeNo material change
    Effective DateApr 4, 2006
    Last ReviewSep 22, 2023
    Next Review DateAug 9, 2024
    Key ActionDocument prior failure or intolerance of non-invasive measures (eg, physical therapy and non-narcotic analgesics) before initial therapeutic TFESI.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12max TFESIs per region per episode
    3sessions per region per 6 months
    4max TFESIs per session
    2min interval (weeks)
    52trials in 2015 review
    8RCTs in 2015 meta-analysis

    Coverage and Medical Necessity Criteria

    COVERAGE CRITERIA

    Covered when ALL of the following are met

    Diagnostic TFESI

    • Clinical findings concordant with nerve root compression within prior 3 months: Loss of named muscle strength OR altered sensation in distribution OR diminished/absent/asymmetric reflexes

      At least one required

    • Objective testing within timeframe: Either concordant MRI/CT radiologist interpretation within prior 12 months OR electrodiagnostic studies (EMG/NCV) diagnostic of nerve root compression

      At least one required

    Initial therapeutic TFESI

    • Prior conservative therapy: Non-invasive measures such as physical therapy and non-narcotic analgesics have failed or been intolerant

      Required before initial therapeutic TFESI

    • Clinical-radiologic concordance: Member has radicular pain that is consistent with radiologic findings

      Required

    Repeat therapeutic TFESI: Additional therapeutic TFESIs with imaging guidance are medically necessary if the initial injection resulted in at least two of the following for at least two weeks: (1) >=50% pain relief, (2) increased level of function/physical activity, (3) reduction in use of pain medication or other medical therapies

    At least two of three criteria must be met for >=2 weeks

    COVERAGE CRITERIA

    Covered when ALL of the following are met

    Initial therapeutic TFESI

    • Prior conservative therapy: Non-invasive measures such as physical therapy and non-narcotic analgesics have failed or been intolerant

      Required before initial therapeutic TFESI

    • Clinical-radiologic concordance: Member has radicular pain that is consistent with radiologic findings

      Required

    Diagnostic TFESI

    • Clinical findings concordant with nerve root compression within prior 3 months: Loss of named muscle strength OR altered sensation in distribution OR diminished/absent/asymmetric reflexes

      At least one required

    Continuation/Repeat Therapy

    Additional therapeutic TFESIs covered if initial response criteria met

    Repeat therapeutic TFESI: Additional therapeutic TFESIs with imaging guidance are medically necessary if the initial injection resulted in at least two of the following for at least two weeks: (1) >=50% pain relief, (2) increased level of function/physical activity (eg, return to work), (3) reduction in the use of pain medication and/or additional medical therapies (eg, physical therapy)

    At least two of three criteria must be met for >=2 weeks

    Limits

    Coverage is limited by the following quantity and frequency rules

    Per-session limits: No more than two contiguous vertebral levels or more than four TFESIs during a single session are medically necessary

    Up to four TFESIs per session (eg, two bilateral TFESIs at two contiguous levels) when other criteria met

    Session frequency limits (6 months): No more than three TFESI sessions per episode of pain per spinal region per 6 months

    Each session may include up to four TFESIs when criteria met

    Episode maximum: Maximum of twelve TFESIs per spinal region administered during a maximum of three sessions for an episode of pain lasting six months

    When criteria met

    Annual session limit: No more than four TFESI sessions per spinal region per 12 months

    Evidence-based coverage considerations

    Summarized evidence and clinical inferences

    General evidence summary: Randomized and observational studies show TFESI can provide short- to intermediate-term pain relief for lumbar and cervical radicular pain; magnitude varies by study and patient selection.

    See individual study details in chunks 18-33.

    Patient groups with reported benefit: Patients with foraminal degenerative stenosis, disc herniation, early radicular pain (<1 year), post-diskectomy recurrent radiculopathy without recurrent herniation, and selected zygapophyseal cyst-related radicular pain have reported benefit in series and trials.

    Supported by chunks 18, 20, 22, 24.

    Comparative outcomes: Meta-analysis of 8 RCTs found a modest analgesic benefit of transforaminal steroids versus local anesthetic/saline at ~3 months but no effect on disability or surgery incidence at 12 months.

    Chunks 32-33.

    The following procedures are considered experimental and investigational because their effectiveness has not been established: diagnostic TFESIs for indications not listed in the Medical Necessity section; intra-operative administration of epidural steroids following percutaneous transforaminal endoscopic discectomy; TESI combined with radiofrequency ablation for lumbar disc herniation; therapeutic TFESIs for indications not listed in Section I; transforaminal or interlaminar epidural steroid injections combined with caudal epidural steroid injections for chronic radicular pain; and ultrasound-guided transforaminal epidural steroid injections.

    A technology assessment from the Institute for Clinical Systems Improvement (ICSI) concluded that epidural steroid injections should be performed with imaging guidance and stated that “epidural steroid injections should not be done without fluoroscopic guidance.” Fluoroscopic guidance (or CT guidance as an acceptable alternative) is therefore the expected imaging method for TFESIs performed for diagnostic or therapeutic purposes, and documentation of imaging guidance is recommended.

    External links included in this policy are provided for convenience only. Aetna is not responsible or liable for the content, accuracy, or privacy practices of non‑Aetna sites; providers should follow Aetna’s administrative guidance and plan‑specific procedures for prior authorization and documentation requirements rather than relying on external sites.

    Coverage is limited by specific procedural and frequency rules. TFESIs at more than two (2) contiguous vertebral levels or more than four (4) TFESIs during a single session are considered not medically necessary. More than three (3) TFESI sessions per episode of pain per spinal region within six (6) months, or more than four (4) sessions per spinal region per twelve (12) months, and TFESI sessions performed more frequently than every two (2) weeks are also considered not medically necessary and may be denied.

    The evidence base includes randomized and observational studies showing short‑ to intermediate‑term pain relief with TFESI in selected patients, but limitations exist. A meta‑analysis of randomized trials reported a modest analgesic benefit at ~3 months versus local anesthetic or saline and found no impact on disability or on incidence of surgery at 12 months. Study heterogeneity, small sample sizes in many trials, variable dosing and procedure frequency, and methodological limitations indicate that larger, well‑designed randomized trials are needed to define optimal dosages, number of procedures, and long‑term outcomes.

    Billing Codes and Coding Guidance

    Covered CPT Codes (if selection criteria met)CPTCovered
    64479Injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or CT); cervical or thoracic, single level
    64480cervical or thoracic, each additional level (List separately in addition to code for primary procedure)
    64483Injection(s), anesthetic agent and/or steroid, transforaminal epidural, with imaging guidance (fluoroscopy or CT); lumbar or sacral, single level
    64484lumbar or sacral, each additional level (List separately in addition to code for primary procedure)
    CPT Codes Not Covered for Indications ListedCPTNot Covered
    64635Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint
    64636lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure)
    Other related CPT/HCPCS Codesmixed
    62320-62323Injection(s), of diagnostic or therapeutic substance(s), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid
    62324-62327Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, interlaminar epidural or subarachnoid
    77003Fluoroscopic guidance and localization of needle or catheter tip for spine or paraspinous diagnostic or therapeutic injection procedures
    77012Computed tomography guidance for needle placement, radiological supervision and interpretation
    97010-97530Physical therapy
    ICD-10 Codes (examples covered if criteria met)ICD-10Covered
    G56.00-G57.93Mononeuropathy of upper and lower limb
    G58.0-G58.7,G58.9Other mononeuropathies
    M50.00-M50.23,M50.90-M50.93Cervical disc disorders
    M51.04-M51.27,M51.9,M51.A0-M51.A5Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders
    M54.10-M54.18Radiculopathy
    M54.30-M54.42Sciatica and lumbago with sciatica
    M79.2Neuralgia and neuritis, unspecified

    Provider Requirements, Documentation, and Billing Alerts

    Billing Rule

    CPT codes requiring criteria

    CPT codes for transforaminal epidural steroid injections (TFESI) require that the selection criteria in this policy are met for coverage.

    • Covered CPT codes when criteria are met: 64479, 64480, 64483, 64484
    • Other related CPT/HCPCS: 62320-62327, 77003, 77012
    Documentation Required

    Fluoroscopy/CT guidance expectation

    Fluoroscopic (or CT) guidance is expected for both diagnostic and therapeutic TFESIs; epidural steroid injections should not be performed without fluoroscopic guidance per referenced technology assessments.

    Clinical Background and Definitions

    Radicular pain (radiculopathy) results from compression or irritation of a spinal nerve root due to causes such as disc herniation, foraminal stenosis, facet cysts, or trauma. Transforaminal epidural steroid injections (TFESIs) are targeted injections of corticosteroid (often with local anesthetic) delivered into the neural foramen around an affected nerve root, typically under fluoroscopic guidance; CT guidance is an acceptable alternative. TFESIs may be used diagnostically to localize a symptomatic nerve root or therapeutically to reduce perineural inflammation and pain as part of a comprehensive pain management program.

    Radiculopathy definition
    DefinitionPain, dysaesthesias, or paresthesias in a specified dermatomal distribution of an involved named spinal root causing significant functional limitations (diminished quality of life and impaired, age-appropriate activities of daily living).
    Clinical contextMay be caused by disc herniation, stenosis, facet cysts, or trauma and is the primary indication for TFESI when concordant with imaging or electrodiagnostic studies.
    Actionable thresholdRequires clinical findings or objective testing concordant with nerve root compression for diagnostic or therapeutic procedures per policy criteria.

    Prerequisite Conservative Care and Surgical Considerations

    Session and Injection Frequency Limits

    TFESI sessions per 6 months
    Allowed sessions per 6 monthsNo more than three (3) TFESI sessions per episode of pain, per spinal region per six (6) months.
    Per-session injectionsEach session may include up to four (4) TFESIs (e.g., two bilateral TFESIs at two contiguous levels) when other criteria are met.
    Denial riskMore than three sessions per spinal region per 6 months is considered not medically necessary and may be denied.
    Maximum TFESIs per spinal region (12 over up to 3 sessions per 6-month episode)
    Maximum per spinal regionMaximum of twelve (12) TFESIs per spinal region administered during a maximum of three (3) sessions for an episode of pain lasting six (6) months.
    Session compositionEach session may include up to four (4) TFESIs (e.g., two bilateral TFESIs at two contiguous levels) when other criteria are met.

    Imaging and Procedural Guidance

    Billing Rule

    TFESI imaging requirement: fluoroscopy or CT

    Imaging guidance for TFESI must be fluoroscopy or computed tomography (CT); diagnostic and therapeutic TFESIs require imaging guidance per policy.

    • Policy: 'imaging guidance (fluoroscopy or CT)'.
    • CT and CT fluoroscopy are acceptable alternatives to fluoroscopy for guiding needle placement.
    Documentation Required

    Imaging preference: fluoroscopy preferred; ultrasound feasible only with verification

    Fluoroscopy is preferred for TFESI; ultrasound-guided TFESI has been used in feasibility studies but should be verified by fluoroscopy per study methods and is considered investigational in policy exclusions.

    • Yang et al (2016) used ultrasound with fluoroscopic verification; success ratio was 85% and radiation dose was lower.
    • Policy lists ultrasound-guided TFESI among experimental/investigational procedures.

    Services Considered Experimental or Not Covered

    The policy lists specific procedures that are not covered, including ultrasound‑guided transforaminal epidural steroid injections and intra‑operative epidural steroid administration following percutaneous transforaminal endoscopic discectomy. These are classified as investigational because current evidence is insufficient to establish their effectiveness.

    Policy Summary
    PayerAetna
    PolicyTransforaminal Epidural Injections
    Policy CodePolicy 0722
    Change TypeNo material change
    Effective DateApr 4, 2006
    Last ReviewSep 22, 2023
    Next Review DateAug 9, 2024
    Key ActionDocument prior failure or intolerance of non-invasive measures (eg, physical therapy and non-narcotic analgesics) before initial therapeutic TFESI.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaBilling Codes and Coding GuidanceProvider Requirements, Documentation, and Billing AlertsClinical Background and DefinitionsPrerequisite Conservative Care and Surgical ConsiderationsSession and Injection Frequency LimitsImaging and Procedural GuidanceServices Considered Experimental or Not Covered
    Objective testing within timeframe: Either concordant MRI/CT radiologist interpretation within prior 12 months OR electrodiagnostic studies (EMG/NCV) diagnostic of nerve root compression

    At least one required

    Therapeutic continuation criteria: Therapeutic TFESIs should be part of a comprehensive pain management program

    See repeat therapeutic TFESI criteria for continuation

    Each session may include up to four TFESIs when criteria met

    Minimum interval: TFESI sessions should not be performed more frequently than every two weeks for any spinal region

    Applies to all spinal regions

    Guidance on imaging/technique:
    ICSI and other reviews recommend fluoroscopic guidance for epidural steroid injections; ultrasound-guided approaches are feasible but lack large definitive effectiveness trials.

    Chunks 24, 26, 27.

  1. Fluoroscopy or CT guidance required for TFESI procedures (see covered CPTs above)
  2. 77003 (fluoroscopic guidance) and 77012 (CT guidance) are the appropriate guidance codes
  3. Prior Authorization

    Prior authorization and policy review

    Prior authorization may be required by the payer; reviewers should consult plan-specific requirements and this policy when determining coverage.

    • Check member’s plan for prior authorization rules before scheduling TFESI
    • This policy effective date: 2006-04-04; most recent review: 09/22/2023; next review: 08/09/2024
    Prior Authorization

    Prior authorization

    Some plans may require prior authorization for TFESI sessions or for exceeding per-session or frequency limits; obtain authorization when indicated by the member’s benefit plan.

    • Obtain prior authorization when required by the member’s plan for TFESI scheduling or for exceeding stated limits
    Billing Rule

    Session frequency limit (6 months)

    Session frequency and per-episode limits must be followed: no more than three TFESI sessions per spinal region per 6 months, and sessions no more frequently than every two weeks.

    • Maximum of 3 TFESI sessions per spinal region per 6 months
    • Minimum interval between sessions: 2 weeks
    Note

    Policy history and review dates

    Policy history and review dates are provided for reference; clinicians and reviewers should use the most recent policy review date when assessing applicability.

    • Effective date: 04/04/2006
    • Last review: 09/22/2023
    • Next review scheduled: 08/09/2024
    • Review history and definitions available via the linked resources
    Denial Risk

    No discrete denial criteria present

    This section of the policy does not list discrete denial criteria; absence of an explicit denial list does not obviate the need to meet the medical necessity criteria and documentation requirements described elsewhere in the policy.

    • No standalone denial criteria block is present in this policy section — denials will be based on failure to meet the documented medical necessity criteria or limits
    Note

    In studies of diagnostic cervical TFESI

    In studies of diagnostic cervical TFESI, many patients experienced meaningful pain reduction and some avoided surgery; evidence indicates roughly half of patients may achieve ≥50% pain reduction at short- to intermediate-term follow-up, though quality of evidence is low.

    • Diagnostic CTFESI may predict need for surgery; in one registry 70% did not require subsequent cervical surgery after diagnostic CTFESI (Costandi et al., retrospective)
    • Systematic review/meta-analysis (Conger et al., 2020) found ~50% achieved ≥50% pain reduction at 1–3 months but evidence quality was very low
    Documentation Required

    Required clinical outcome documentation

    Document clinical outcomes after TFESI per the policy: pain relief (percent reduction and duration), functional improvement, and changes in analgesic use — these data are required to justify additional therapeutic injections.

    • Document at least two of the following after an initial therapeutic TFESI for consideration of additional injections: ≥50% pain relief, increased function/physical activity (eg, return to work), reduction in pain medication or adjunctive therapies
    • Record outcome duration (eg, ≥2 weeks) and objective measures when available
    Documentation Required

    Conservative measures prerequisite

    Conservative measures must be attempted and documented prior to initial therapeutic TFESI: non-invasive measures such as physical therapy and non-narcotic analgesics should have failed or been intolerable.

    • Documentation of trial and failure or intolerance of conservative therapy (physical therapy, non-narcotic analgesics) is required before an initial therapeutic TFESI
    • Document neurologic exam within prior 3 months and concordant MRI/CT or EMG/NCV within prior 12 months as applicable
    Note

    Evidence on corticosteroid TFESI and surgery avoidance

    Evidence suggests TFESI with corticosteroid is more effective than local anesthetic alone for avoiding surgery in selected lumbar radiculopathy patients; consider TFESI prior to operative intervention in appropriate candidates.

    • Riew et al. (2000): bupivacaine plus betamethasone group had significantly lower subsequent surgery rates versus bupivacaine alone
    • Consider TFESI with corticosteroid for patients with 1–2 level lumbar radiculopathy prior to surgery when clinically appropriate
    Step Therapy

    Step therapy note

    Some plans may implement step therapy or other utilization management approaches; follow plan-level step therapy requirements when applicable.

    • Step therapy may require conservative treatments prior to authorization of TFESI — verify plan-specific policies
    Note

    Links to Aetna resources

    Links to Aetna resources and glossary are provided for convenience; documentation requirements may reference these external Aetna resources.

    • Glossary: https://www.aetna.com/glossary.html
    • Aetna site links for member resources, policies, review history and definitions (see policy header and Additional Information)
    Therapeutic TFESI definition
    DefinitionAn injection with imaging guidance (fluoroscopy or CT) intended to reduce inflammation and pain around a spinal nerve root as part of a comprehensive pain management program.
    IndicationInitial therapeutic TFESI is covered when non-invasive measures (physical therapy and non-narcotic analgesics) have failed or been intolerable and radicular pain is consistent with radiologic findings.
    DocumentationTherapeutic TFESIs should be administered as part of a comprehensive pain management program; response criteria are required for repeat injections.
    Diagnostic TFESI definition
    DefinitionA selective transforaminal epidural steroid injection with imaging guidance (fluoroscopy or CT) used to identify the etiology of pain in patients with symptoms suggestive of chronic radiculopathy when diagnosis remains uncertain after standard evaluation.
    Standard evaluationStandard evaluation includes neurological examination, radiological and neurodiagnostic studies; diagnostic TFESI is used when these are inconclusive.
    PurposeTo establish the diagnosis of radiculopathy when clinical findings and imaging/neurodiagnostic tests are discordant or nondiagnostic.
    Fluoroscopically guided ESI definition
    DefinitionEpidural steroid injections performed under fluoroscopic imaging control; considered generally safe when performed by an experienced physician in a controlled setting.
    RecommendationICSI technology assessment: epidural steroid injections should not be done without fluoroscopic guidance.
    Common agentsCommonly used corticosteroids include methylprednisolone and betamethasone as noted in the ICSI assessment.
    Ultrasound-guided TFEI note
    DefinitionTransforaminal epidural injection performed using ultrasound visualization; feasibility and reduced radiation have been reported in small studies but clinical effectiveness requires further research.
    Study findingsYang et al (2016): ultrasound-guided lumbar TFEI was feasible, safe, had lower radiation exposure and shorter procedure time but was a feasibility study needing larger trials for effectiveness confirmation.
    VerificationIn the referenced study ultrasound-guided injections were verified by fluoroscopy, indicating combined verification was used.
    TFESI (abbreviation/term)
    TermTFESI = Transforaminal epidural steroid injection (steroid injected via the neural foraminal/transforaminal approach, usually under fluoroscopic guidance, targeted to the affected nerve root).
    UsageUsed diagnostically to localize symptomatic nerve roots and therapeutically to reduce perineural inflammation and pain.
    ImagingTypically performed under fluoroscopic guidance; CT is an acceptable alternative.
    CESI (abbreviation/term)
    TermCESI = Caudal epidural steroid injection (steroid delivered via a caudal/sacral epidural approach).
    Relation to TFESICESI may be combined with TFESI in some studies for treatment of chronic radicular pain; comparative effectiveness varies by study.
    Clinical noteUsed as an alternative epidural approach depending on clinical circumstances and anatomy.
    RFA (abbreviation/term)
    TermRFA = Radiofrequency ablation — a thermal lesioning technique to disrupt nociceptive pathways; sometimes combined with TFESI in treatment of lumbar disc herniation.
    Clinical useCombined TFESI + RFA has been used in retrospective studies with reported longer-term improvement in pain and function compared with TFESI alone.
    Evidence noteLarger, multicenter trials are needed to confirm long-term benefits of combined approaches.
    Applies toLimit applies per spinal region (cervical, thoracic, or lumbar) for an episode of pain.
    TFESI sessions per 12 months
    Allowed sessions per 12 monthsNo more than four (4) TFESI sessions per spinal region per twelve (12) months.
    Per-session injectionsEach session may include up to four (4) TFESIs when other criteria are met.
    Denial riskMore than four sessions per spinal region per 12 months is considered not medically necessary and may be denied.
    Minimum interval between sessions
    Minimum intervalTFESI sessions should not be performed more frequently than every two (2) weeks for any spinal region.
    Denial riskSessions performed more frequently than every two weeks are considered not medically necessary and may be denied.
    Applies toThis interval requirement applies to cervical, thoracic, and lumbar regions.
    Study settings allowed up to 4 injections in trial settings
    Trial settings noteSome trials allowed up to four (4) injections (patients were permitted to receive as many as four injections in Riew et al. and other studies had variability in frequency and number of procedures).
    ContextThese trial allowances influenced study outcomes but do not override policy frequency limits used for coverage determinations.
    Evidence variabilityThere is variability across studies in dose, frequency, and number of procedures; meta-analyses note heterogeneity in protocols.
    CTFESI literature note (fluoroscopic emphasis, no numeric limits)
    CTFESI literature noteFluoroscopically guided cervical transforaminal epidural steroid injection (CTFESI) cohort studies report approximately 48–55% of patients achieving ≥50% pain relief at short- to intermediate-term follow-up, but evidence quality is very low and randomized controlled comparisons are lacking.
    Imaging emphasisPolicy and cited reviews emphasize fluoroscopic guidance for CTFESI; studies often lack numeric frequency limits and vary in protocol.
    Research needAuthors recommend randomized trials with placebo/sham or active comparison groups to determine effectiveness and efficacy of CTFESI.
    Note

    Imaging modalities discussed: fluoroscopy, CT and MRI referenced

    The literature and policy discuss multiple imaging modalities (fluoroscopy, CT, MRI) used for diagnosis and guidance; fluoroscopic guidance is the common requirement for TFESI and selective nerve root blocks.

    • Studies reference MRI/CT for diagnostic correlation and fluoroscopy/CT for procedural guidance.
    • Fluoroscopic guidance is emphasized as standard in most cited studies and reviews.